U.S. federal trademark · Serial No. 74089700 · Reg. No. 1790060
house mark for drugs, pharmaceuticals, and reagents used in the diagnosis monitoring and treatment of cancer, infectious diseases, and auto-immune disorders
research, development services in the field of immunotherapeutic substances; patient monitoring and treatment; clinical testing; medical therapy and immunotherapy; and immunodiagnostic services and monitoring thereof
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.